US equities
|
ANT
$95.91
▲+15.55%
NVDA
$149.25
▼-1.13%
AMD
$480.56
▼-9.35%
MU
$704.60
▼-0.09%
SPCX
$137.28
▼-4.33%
SNDK
$776.29
▲+0.01%
AMZN
$260.69
▼-2.63%
AAPL
$349.14
▼-0.94%
ANT
$95.91
▲+15.55%
NVDA
$149.25
▼-1.13%
AMD
$480.56
▼-9.35%
MU
$704.60
▼-0.09%
SPCX
$137.28
▼-4.33%
SNDK
$776.29
▲+0.01%
AMZN
$260.69
▼-2.63%
AAPL
$349.14
▼-0.94%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
(TSV:
PAIN
)
2.530
-0.030 (-1.17%)
Delayed Quote
Updated: 1:25 PM EST, Nov 19, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PAIN
Beyond GLP-1: The Next Wave of Peptide Innovation Could Unlock Billions in Biotech Growth
Today 8:45 EST
GLP-1 Treatments, Anticancer Research, and Emerging Therapeutic Technologies Are Driving the Next Chapter of Pharmaceutical Innovation
From
FN Media
Via
GlobeNewswire
Beyond GLP-1: The Next Wave of Peptide Innovation Could Unlock Billions in Biotech Growth
Today 8:35 EST
EQNX::TICKER_START (OTCQB:PNGAF),(CSE:BPC),(NYSE:LLY),(NYSE:HIMS),(TSXV:PAIN),(CSE:VLAB) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Intellectual Property